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Conclusions. BMP-7 represses the basal and TNF-–stim-BMP-7 regulates chemokine, cytokine, and hemodynamic gene
ulated expression of the pro-inflammatory cytokines IL-6 andexpression in proximal tubule cells.
IL-1, the chemokines MCP-1 and IL-8, and the vasoconstric-Background. Proximal tubule epithelial cells (PTEC) play
a central role in the response of the kidney to insult by virtue tor ET-2 in PTEC. This data are consistent with the in vivo
of their production of chemokines and cytokines that signal an observations that BMP-7 administration in a model of chronic
inflammatory response. Bone morphogenic protein-7 (BMP-7/ and acute renal failure results in a reduction in the infiltration
OP-1), a member of the transforming growth factor- (TGF-) of macrophages in the renal interstitium. Taken together, these
superfamily, has previously been demonstrated to reduce mac- observations suggest that BMP-7 may be a novel therapeutic
rophage infiltration and tissue damage in animal models of acute agent for kidney disorders involving inflammation and ischemic
and chronic renal failure. The present study was designed to de- damage of PTEC.
fine the molecular mechanism of BMP-7 action in human PTEC.
Methods. Expression of BMP-7 in the adult mouse kidney
was determined indirectly through X-gal staining of heterozy-
gous BMP-7/lacZ mice in combination with cell-type specific The most common cause of injury leading to acute
markers. Primary human PTEC were cultured in the presence renal failure is ischemia. Moreover, proximal tubular epi-
of the pro-inflammatory cytokine, tumor necrosis factor- thelial cells play an important role in ischemia-induced(TNF-), with and without BMP-7. RNA isolated from these
disease [1]. Proximal tubule epithelial cells (PTEC) cellstwo populations was then used to identify differentially regu-
lated genes via gene-array analysis. Modulation of potential tar- are the major site of necrosis associated with renal is-
get genes was subsequently confirmed through ELISA and/or chemia, and the extent of tubulointerstitial damage is a
quantitative PCR. better predictor of kidney function and clinical outcomeResults. Expression from the BMP-7/lacZ transgene was de-
than the extent of glomerular damage in cases of chronictected in the collecting duct, thick ascending limb, distal convo-
luted tubule, and podocytes within glomeruli. No expression renal failure [2]. Tubular epithelial cells (TECs) produce
was detected within PTEC; however, these cells were found to a number of pro-inflammatory cytokines including tumor
express mRNA for BMP receptors including, ActR-I, BMPR-IA, necrosis factor- (TNF-) and interleukin-6 (IL-6), che-ActR-II, ActR-IIB, and BMPR-II. BMP-7 significantly reduced
mokines such as monocyte chemotactic protein-1 (MCP-1),TNF- stimulated increases in mRNA for the pro-inflamma-
tory genes, interleukin-6 (IL-6) and interleukin-1 (IL-1), and RANTES (regulated on activated normal T-cell ex-
the chemoattractants monocyte chemotactic protein-1 (MCP-1) pressed), and interleukin-8 (IL-8), and cytokines such as
and interleukin-8 (IL-8) in primary human PTEC. In addition, transforming growth factor-1 (TGF-1) [3–6]. ReleaseBMP-7 also reduced the expression of mRNA for endothelin-2
of pro-inflammatory cytokines and chemokines by tubu-(ET-2), a vasoconstrictor, and increased the expression of
mRNA for heme oxygenase-1 (HO-1), a vasodilator, although lar epithelial cells contribute to the extent of tissue dam-
the latter was not statistically significant. In experiments de- age by attracting and activating infiltrating leukocytes in
signed to examine MCP-1 and IL-6 protein levels in response the renal interstitium [4].to additional TGF- superfamily members, TGF-1 was unable
Bone morphogenic protein-7 is a member of theto mimic the effects of BMP-7 in reducing IL-6 production.
However, the closely related BMP-6 exhibited similar proper- TGF- superfamily of ligands that is required during
ties to those of BMP-7. Each of the factors reduced MCP-1 embryogenesis for normal skeletal, kidney, and eye de-
expression. velopment [7–9]. In the kidney BMP-7 is thought to be
required in the metanephric mesenchyme for continued
1 See Editorial by Kopp, p. 351. epithelial tubule development in the embryonic kidney
[7]. The expression of BMP-7 continues in the adultKey words: bone morphogenic protein-7, proximal tubule, anti-inflam-
matory, hemodynamic, IL-6, IL-1, MCP-1, IL-8, ET-2, TGF-1. kidney and this expression has been suggested to de-
crease in response to injury [10, 11]. Administration ofReceived for publication April 11, 2001
BMP-7 to animals in a model of renal ischemia has beenand in revised form August 12, 2001
Accepted for publication August 15, 2001 reported to increase survival [12]. The increase in sur-
vival was found to correlate with a decrease in the re- 2002 by the International Society of Nephrology
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sulting infarct size, necrosis, and infiltration and activity limb were identified by immunoreactivity with rabbit
anti-Tamm-Horsfall protein (THP) antisera (Biodesignof neutrophils following reperfusion [12]. Similar results,
including reductions in monocyte/macrophage accumu- International, Saco, ME, USA) at 34g/mL for one hour
at room temperature followed by visualization with bio-lations, have recently been reported following adminis-
tration of BMP-7 in a model of unilateral ureteral ob- tinylated anti-rabbit secondary, streptavidin-HRP, and
DAB chromogenic substrate (Histostain-Plus; Zymed).struction that mimics some aspects of progressive chronic
renal failure including interstitial fibrosis [13]. Whole-mount specimens were postfixed as above and
processed through a graded glycerol series to 80% glyc-Our study was initiated to identify the mechanisms by
which BMP-7 promotes recovery from, or reduces injury erol for photography.
associated with such renal insults. We describe the de-
Cell culture and RNA isolationtailed cellular expression of BMP-7 in the adult murine
kidney and use gene array analysis to identify genes Human proximal tubule epithelial cells (PTEC) were
obtained from Clonetics (Walkersville, MD, USA) andregulated by BMP-7 in primary human proximal tubule
cells. We have found that BMP-7 acts to significantly passaged in the recommended media, REBM contain-
ing 0.1 mg/mL recombinant human epithelial growthreduce the expression of pro-inflammatory cytokines in-
cluding IL-6 and IL-1, the chemokines IL-8 and MCP-1, factor (rhEGF), 0.05 mg/mL insulin, 5g/mL hydrocorti-
sone, 5 g/mL epinephrine, 0.56 mg/mL triiodothyro-and the vasoactive peptide endothelin-2 (ET-2). The
ability to reduce the production of MCP-1 and IL-6 pro- nine, 0.1 mg/mL transferrin, 0.25 mg/mL gentimycin, and
0.25 mg/mL amphotericin-B, except that it contained 2%tein in PTEC was shared by BMP-6, a closely related
BMP family member, whereas TGF-1 was found to fetal bovine serum (FBS) instead of 0.5% FBS. In all
cases cells were used between passages 4 and 5. For genereduce MCP-1 production, but not IL-6 production by
PTEC. These observations support a mechanism by array and quantitative polymerase chain reaction (PCR)
analysis PTEC were plated on standard tissue culturewhich BMP-7 reduces renal injury by decreasing the
infiltration and activation of neutrophils through re- plastic and grown to 70 to 80% confluence prior to treat-
ment. BMP-7 (mature formulation; Curis, Inc.) and/orduced chemokine and cytokine expression, and by main-
taining blood flow to the kidney through a reduction in TNF- (R&D Systems, Minneapolis, MN, USA) was then
added to REBM media without additives and con-vasoconstrictive peptide gene expression.
taining 0.5% FBS. For analysis of dose dependence, time
course analysis, and enzyme-linked immunosorbent as-
METHODS
say (ELISA), PTEC cells were plated on collagen-I coated
BMP-7/lacZ transgene localization culture dishes (Becton Dickenson, Franklin Lakes, NJ,
USA). Analysis of a select set of markers revealed no sig-BMP-7/lacZ mice were generously provided by Dr.
Elizabeth Robertson [8]. Transgene expression was de- nificant differences in response between cells grown on
collagen-I coated plates and those grown on tissue cul-tected via -gal staining as described [8]. Following post-
fixation in 4% paraformaldehyde/phosphate-buffered ture plastic. RNA isolations were carried out via the
Atlas Pure Total RNA isolation system (Clontech, Palosaline (PBS), kidneys were embedded in paraffin through
a graded ethanol series into xylenes keeping the total Alto, CA, USA) or by the Stratagene 96-well total RNA
isolation kit (Stratagene, La Jolla, CA, USA) followingtime in xylenes under 20 minutes. Serial 3-m sections
were cut and processed for further histochemical analysis the manufacturer’s recommendations.
according to standard protocols. Proximal tubules were
Gene array analysisidentified by staining for alkaline phosphatase (AP) via
an initial equilibration in AP buffer [100 mmol/L Tris- Thirty micrograms of PTEC total RNA was used to
generate 33P-labeled probes using the Atlas Pure TotalHCl, pH 9.5; 50 mmol/L MgCl2; 100 mmol/L NaCl; 0.1%
Tween 20 (vol/vol)] for 15 minutes at room temperature RNA labeling system (Clontech). Probes were hybrid-
ized to the Atlas Human 1.2 array containing 1176 knownfollowed by an incubation in the same buffer containing
fast red (1 fast red tablet/2 mL; Roche Molecular Bio- genes and hybridization detected with a Cyclone phos-
phoimager (Packard Instruments, Meriden, CT, USA).chemicals, Indianapolis, IN, USA) for two hours at 37C.
Collecting ducts were identified by immunostaining with Quantitation was performed using the Atlas Image anal-
ysis software package (V 1.01; Clontech). A ratio of 1.8biotinylated Arachis hypogea lectin (Sigma, St. Louis,
MO, USA) at 10 g/mL for one hour at room tempera- was taken as the minimum threshold for reporting sig-
nificant differences between blots. Within a single blotture. Biotinylated lectin was then visualized using strep-
tavidin-horseradish peroxidase (HRP) and diaminoben- genes were considered expressed if they had values
greater than twice background. Blots were normalizedzidine (DAB) chromogenic substrate according to the
manufacturer’s recommendations (Histostain-Plus; Zy- for probe activity based on the hybridization signal of
40S ribosomal protein S9. A value of “undefined” indi-med, South San Francisco, CA, USA). Thick ascending
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Table 1. Primers used for polymerase chain reaction (PCR)
Gene Forward Reverse
18S rRNA 5-GCCGCTAGAGGTGAAATTCTTG-3 5-CATTCTTGGCAAATGCTTTCG-3
HO1 5-GCCCTGCCCTCCAGCAT-3 5-TTGAGACAGCTGCCACATTAGG-3
IL-1 5-ATGTGCACGATGCACCTGTAC-3 5-TCATATGGACCAGACATCACCAA-3
Id-1 5-AGAACCGCAAGGTGAGCAA-3 5-TCCAACTGAAGGTCCCTGATG-3
Id-2 5-CCACCCTCAACACGGATATCA-3 5-ACACAGTGCTTTGCTGTCATTTG-3
Id-3 5-GCGGCAGAGCTGGTCTTC-3 5-TCAGGGCAACAGAACCTTTCTC-3
Sky 5-GAAGCCCGGACTGACCAA-3 5-CATCAAGCCAAGGCCTAAACTG-3
Smad6 5-GCCACTGGATCTGTCCGATT-3 5-CACCCGGAGCAGTGATGAG-3
MCP-1 5-CGCCTCCAGCATGAAAGTCT-3 5-GGGAATGAAGGTGGCTGCTA-3
IL-6 5-GGCTGCAGGACATGACAACTC-3 5-TGAGGTGCCCATGCTACATTT-3
IL-8 5-AGATATTGCACGGGAGAATATACAAA-3 5-TCAATTCCTGAAATTAAAGTTCGGATA-3
AODRA1 5-CCACAAGCCCAGCATCCTT-3 5-GGGTTCATGGCCGAGTTG-3
ET-1 5-CCCTCCAGAGAGCGTTATGTG-3 5-TGGAGGCTATGGCTTCAGACA-3
ET-2 5-AAGGCTGAGGGACATTTCC-3 5-TGTTGTCGCTTGGCAAAG-3
ICAM-1 5-CATGTGTAGCATCAAAACACAAAGG-3 5-GGTAAAATAACAAATGAATAAATACATATCATCA-3
Gro 5-GGAGGCCCTGCCCTTACA-3 5-CAAACACATTAGGCGCAATCC-3
ActR-IIB 5-CAAGCAGTCGTGGCAGAG-3 5-ATGGTCACACAAAGTGGG-3
ActR-II 5-GGATGTCTCTTGGAAATGTTAAGA-3 5-TTTATGTACACAGAACAGCAGCA-3
BMPR-IA 5-TGAAATCAGACTCCGACC-3 5-TGCTTGAGATGCTCTTGC-3
BMPR-IB 5-GTTCCCTTTATGATTATCTGAAGTCC-3 5-TTAGACACTCATCACTGCTCCAC-3
ActR-I 5-ATGATTGCTCTCCCCTCC-3 5-CACCATACCTGCCTTTCC-3
BMPR-II 5-ATCCGTATCAGCAAGACC-3 5-GCAGTGACTCTCTCATCTCC-3
Beta actin 5-CTGGAACGGTGAAGGTGACA-3 5-CGGCCACATTGTGAACTTTG-3
cates that one of the two groups being compared had insulin, 5 g/mL hydrocortisone, 5 g/mL epinephrine,
0.56 mg/mL triiodothyronine, 0.1 mg/mL transferrin,no detectable signal (less than twice background) and
therefore no ratio could be determined. 0.25 mg/mL gentimycin, and 0.25 mg/mL amphotericin-B
(Clonetics, Walkersville, MD) with 2% FBS. BMP-7 was
RT-PCR and quantitative RT-PCR added to REBM media containing 0.5% FBS without
cDNA was generated by reverse transcribing 1 to 2 g growth supplements. Media was withdrawn following
of DNAse-treated total RNA in a reaction volume of 24 hours of BMP-7 treatment for ELISA analysis. MCP-1
20 L using oligo-dT as a priming agent and a commer- was detected in PTEC culture media using a competitive
cial reverse transcription system (Promega, Madison, sandwich ELISA (Biosource International) and IL-6 de-
WI, USA). cDNA was diluted to a 100 L with water tected using a sandwich ELISA (R & D Systems, Minne-
and 2 L of this pool used as template for 25 L PCR apolis, MN, USA), both following the recommendations
reactions. Quantitative real-time TaqMan PCR was per- of the manufacturer.
formed using a PE Biosystems 5700 SDS with SYBR
Green core reagents (PE Biosystems, Foster City, CA, RESULTS
USA). Reactions were performed in triplicate and ana-
Localization of BMP-7 in the adult kidneylyzed via relative quantitation with data presented as
To identify the mechanism by which administration ofdifferences from basal levels of expression in untreated
BMP-7 protects renal function following ischemic insult,PTEC. All data are presented after normalization to 18S
we initially defined the cellular distribution of BMP-7rRNA to account for differences in cell number. cDNAs
within the adult mouse kidney. Previous studies have docu-were further diluted 1:10 prior to analysis of 18S rRNA
mented the cellular distribution of BMP-7 during murineto maintain similar amplification profiles to those of
kidney development [7, 9, 14, 15], but the available dataother gene amplification products in the assay (Table 1).
are less complete for distribution in adult kidneys. To pre-BMP receptor expression was determined via amplifica-
cisely map BMP-7 expression in the adult kidney, micetion of 2 L of cDNAs using 50 L reactions containing
heterozygous for a null BMP-7 allele (BMP-7/-galac-15 mmol/L MgCl2 with the following cycling parameters:
tosidase insertion) were used, which allowed us to indi-94C for two minutes, 30 cycles of 94C at 30 seconds,
rectly localize BMP-7 expression through the analysis of60C for one minute, and 72C for 45 seconds. One tenth
-galactosidase expression [8]. Examination of a kidneyof the products were loaded on an agarose gel for visual-
stained for X-gal in whole-mount reveals abundant BMP-7ization.
expression with increased expression in the medulla and
MCP-1 and IL-6 ELISA ureter, relative to the cortex (Fig. 1 A, B). Analysis of
sections of stained kidneys, in combination with cell-typeProximal tubule epithelial cells were plated on col-
lagen-I coated 24 well plates (Becton Dickenson) in specific markers, localized the majority of BMP-7 expres-
sion to the tubular epithelium (Fig. 1 C–H). BMP-7 wasREBM containing 0.1 mg/mL rhEGF, 0.05 mg/mL
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Fig. 1. Cellular localization of bone morphogenic protein-7 (BMP-7) in the adult mouse kidney. Heterozygous BMP7/lacZ mice were used to
evaluate expression of BMP-7 transcripts in adult mice. X-gal staining in blue indicates BMP-7/lacZ expression. (A and B) Whole mount preparation
of an adult kidney demonstrating abundant expression of BMP-7 in the medullary region and ureter. Expression is also detected in the cortical
region albeit to a lesser extent. (C ) A section of a similarly stained kidney demonstrating BMP-7/lacZ expression in podocytes within the glomerulus.
(D and E) Adjacent sections stained for alkaline phosphatase (AP, red) marking proximal tubules and the lectin Arachis hypogea (AH) marking
collecting ducts (brown). Note that the x-gal staining does not co-localize with the AP, demonstrating that the BMP-7/lacZ transcripts are not
expressed in proximal tubules (pt). There is, however, overlap between AH staining and x-gal indicating that a subset of the BMP-7 expression
includes collecting ducts (cd). (F–H) Adjacent sections stained for (F) Tamm-Horsfall protein (THP) marking the thick ascending limb (brown),
(G) both AH and THP marking both collecting ducts and thick ascending limb, or (H) AH marking the collecting ducts. The arrowhead marks
the same collecting duct present in each section.
detected in collecting ducts marked by Tamm-Horsfall sion were those that have been reported to survive is-
protein (THP), the thick ascending limb, marked by the chemia-induced renal damage. Proximal tubules, which
lectin Arachis hypogea (AH), and by virtue of the contin- lack detectable BMP-7 expression, and the thick as-
uous expression between these two segments within the cending limb have been reported to be extremely sensi-
intervening distal convoluted tubule (Fig. 1 D–H). Ad- tive to ischemic insults [1, 2, 16–19]. This observation
ditional BMP-7 was detected in the glomerulus within raises the possibility that exogenous administration of
podocytes (Fig. 1C). No detectable expression of BMP-7 BMP-7 provides proximal tubule cells with a source of
was observed in proximal tubules, thin descending limb, BMP-7 that then serves to act as a survival factor for
loop of Henle, or in the peritubular vasculature (Fig. 1D). these cells. Therefore, we sought to characterize the mo-
lecular response of PTEC to BMP-7. As a first measure
BMP receptor expression within PTEC cells of response the BMP receptor complement present on
human primary PTEC was defined. These cells wereInterestingly, with the exception of the thick ascending
limb, the epithelial structures exhibiting BMP-7 expres- found to express all known type I and type II BMP
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and MAL, a protein involved in the apical transport path-
way in epithelial cells to undetectable levels (Table 2).
Since it is possible that the changes in gene expression
noted 48 hours following BMP-7 treatment are due to
secondary factors released in response to BMP signaling,
the time-course of BMP-7 effects was analyzed on a se-
lect set of genes identified by gene array. The effects of
Fig. 2. Bone morphogenic protein (BMP) receptor expression in proxi- BMP-7 on Id-3, MCP-1, and ET-2 mRNA expression
mal tubule epithelial cells (PTEC). PTEC were treated for 6 hours in were noted from 0.5 (MCP-1 and Id-3) to 3.0 (ET-2)
the presence of 0 or 100 ng/mL BMP-7 and analyzed for BMP receptor
hours following BMP-7 treatment, suggesting that theseexpression via RT-PCR. Unstimulated PTEC express detectable levels
of ActR-I, BMPR-II, ActR-II, and ActR-IIB. Stimulated PTEC express changes in gene expression are likely due to a direct ef-
these and in addition, contain detectable transcripts for BMPR-IA. fect of BMP signaling (Fig. 3). Consistent with this obser-
Table 1 lists the primer sequences used for PCR.
vation, gene-array analysis performed on cells treated
with BMP-7 and or TNF- for six hours revealed a simi-
lar set of genes whose expression is modified as those
identified following a 48 hour treatment, with the excep-receptors excluding the type I receptor, BMPR-IB as
defined by RT-PCR (Fig. 2). Notably, no BMPR-IA was tion of ICAM-1 (data not shown).
detected in PTEC prior to stimulation with BMP-7, and
BMP-7 reduces expression of chemotactic,the levels of ActR-I, ActR-II, and BMPR-II appeared
inflammatory and vasoactive genes in PTECto increase following BMP-7 treatment. This semiquanti-
tative analysis suggests that PTEC express the appro- Given the prominent representation of genes involved
in inflammatory and hemodynamic regulation regulatedpriate receptors for BMP-7 signaling and, based on the
change in receptor expression following BMP-7 treat- by BMP-7 detected by gene array, it seemed reasonable
to confirm and extend these findings to other genes withment, further suggests that these cells are capable of
responding to this ligand. similar function using more quantitative analyses than
gene array. Quantitative real-time PCR was therefore
Gene array analysis performed using primer sets directed against pro-inflam-
matory, chemokine, and hemodynamic regulators. BMP-7The effects of BMP-7 treatment on PTEC were com-
pared in the presence and absence of the pro-inflamma- treatment for a period of six hours significantly reduced
the TNF--induced expression of the pro-inflammatorytory cytokine TNF- on the expression of a panel of 1176
known human genes. The percentage of genes on the genes IL-6, IL-1, and ADORA1, and the chemokines
MCP-1 and IL-8 (2.7-, 3.6-, 2.4-, 2.9- and 2.0-fold, respec-blots with detectable expression (greater than twice back-
ground) ranged between 24% for untreated and 29% for tively; Fig. 4A). BMP-7 also significantly inhibited the
basal expression of these genes in the absence of TNF-.BMP-7–treated representing 284 to 338 separate genes
(data not shown). Addition of BMP-7 to cells treated BMP-7 had a similar effect on growth-related oncogene
(Gro), a chemokine, although this reduction was notwith TNF- caused a detectable (see Methods section
for analysis thresholds) change in the expression of 40 statistically significant (Fig. 4A). No changes were noted
in RANTES (data not shown). In addition, BMP-7 sig-genes, 8 that increased and 32 that decreased in response
to BMP-7 (Table 2). Of the genes that increased most nificantly reduced the level of endothelin-2 (ET-2, 4.6-
fold) while increasing the expression of ET-1 by 3.2-fold.dramatically in response to BMP-7, three (Id-1, Id-2, and
Id-3) belong to a family of negative regulators of bHLH We also examined the expression of several other damage-
related genes in this system and either failed to detect ortranscription factors [20]. In addition to these genes,
heme oxygenase-1 (HO-1), an enzyme implicated in va- found no changes in the expression of cyclooxygenase 2
(COX2), endothelial nitric oxide synthase (eNOS), in-sodilation was found to increase threefold in response
to BMP-7. Similar increases were noted in the absence ducible nitric oxide synthase (iNOS), angiotensin II (Ang
II), and angiotensin-converting enzyme (ACE). In addi-of TNF- suggesting that these genes may be directly
regulated by BMP-7 (Table 2). Genes identified as hav- tion, no changes in ICAM-1 expression were noted six
hours following BMP-7 treatment. However, both theing their expression reduced greater than 1.8-fold fol-
lowing BMP-7 treatment included the inflammatory or endogenous and TNF--induced expression of ICAM-1
were reduced 2.9-fold following 48 hours of BMP-7 treat-stress response genes, adenosine A1 receptor (ADORA1),
monocyte chemotactic protein-1 (MCP-1), corticotro- ment as assayed by quantitative PCR in close agreement
with data obtained by gene array (data not shown).pin-releasing factor receptor 1 (CRF-1), clusterin (CLU),
intercellular adhesion molecule-1 (ICAM-1), IL-6 and Bone morphogenic protein-7 treatment stimulated the
expression of Id-1 Id-2, Id-3, Smad-6, and SKY approxi-TNF-. In addition, BMP-7 treatment also reduced the
expression of the vasoconstrictor, endothelin-2 (ET-2), mately equally in the presence or absence of TNF-
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Table 2. Genes identified by gene array
Gene BMP-7/TNF- BMP-7 TNF-
Helix-loop-helix protein; DNA-binding protein inhibitor ID-1; Id-1H  ud ud nc
Helix-loop-helix protein; DNA-binding protein inhibitor ID-3; Id-3  ud ud nc
GTP-binding protein ras associated with diabetes (RAD1)  ud nc nc
Heme oxygenase 1 (HO1) 3 ud* 0
Helix-loop-helix protein; DNA-binding protein inhibitor Id-2 2.58 ud 0
Endothelial plasminogen activator inhibitor-1 precursor (PAI1) 2.18 3.55 2.39
Tyrosine-protein kinase receptor tyro3 precursor; rse; sky; dtk 2.16 ud*  ud*
Sodium/potassium-transporting ATPase alpha 1 subunit (Na/K-ATPase) 1.88 1.37* 2.13*
Growth arrest & DNA-damage-inducible protein (GADD45) 1.83 ud*  ud*
Golgi 4-transmembrane spanning transporter; MTP 1.85 0 2.78
Calcium/calmodulin-dependent protein kinase I (CAMKXI) 1.86 nc  ud*
Activated RNA polymerase II transcriptional coactivator p15 1.86 ud*  ud
Alpha-1-antitrypsin precursor 1.86 1.10* 2.14
Cellular nucleic acid binding protein (CNBP) 1.87 nc  ud*
Interleukin enhancer-binding factor (ILF) 1.87 nc  ud*
Cyclin-dependent kinase 4 inhibitor (CDK4I) 1.88 1.09* 1.92*
Prothymosin alpha (ProT-alpha) 1.88 1.32* 1.14*
HLA class I histocompatibility antigen C-4 alpha subunit (HLAC) 1.90 1.35 2.50
Major prion protein precursor (PRP) 1.93 nc  ud*
LIM domain kinase 1 (LIMK-1) 1.94 nc  ud*
ras-related protein RAB2 1.94 ud*  ud*
Transcription factor ZFM1 1.94 1.1* 2.32*
Matrix metalloproteinase 7 (MMP7) 1.95 1.45* 1.90
Alpha1 catenin (CTNNA1) 1.98 1.12 1.11*
Tumor necrosis factor precursor (TNF-) 2.06 1.45* 1.62
Tissue inhibitor of metalloproteinases 2 (TIMP2) 2.06 nc  ud*
B94 protein 2.12 1.04* 1.80
acyl-CoA-binding protein (ACBP) 2.13 1.02 2.36
Interleukin-6 precursor (IL-6) 2.14 1.23* 1.4
Brain-specific tubulin alpha 1 subunit (TUBA1) 2.14 1.33 1.39
Transcriptional regulator interferon-stimulated gene factor 3 gamma subunit 2.19 1.11* 1.47*
14-3-3 protein beta/alpha; protein kinase C inhibitor protein-1 (KCIP-1) 2.19 ud*  ud*
Sodium- & chloride-dependent taurine transporter 2.31 ud*  ud*
Intercellular adhesion molecule-1 precursor (ICAM-1) 2.52 1.35 2.33
Clusterin precursor (CLU) 2.53 1.81* 1.03*
Monocyte chemotactic protein 1 precursor (MCP-1) 2.88 1.43 3.78
Corticotropin releasing factor receptor 1 precursor (CRF-1) 2.98 1.37* 1.78*
Adenosine A1 receptor (ADORA1) 4.10 1.82 2.0
T-lymphocyte maturation-associated protein MAL  ud nc  ud*
Endothelin 2 (ET-2)  ud 1.04* 1.69*
Results from gene array analysis. Only those genes whose expression was altered greater than 1.8-fold in response to addition of BMP-7 in the presence of TNF-
are listed (BMP-7/TNF-). Comparisons are presented as a ratio of treated/untreated. In cases where one of the two samples contained undetectable (less than twice
background) signal and no ratio could be determined the value is stated as  or  undetermined (ud) depending on whether the treated ( ud), or the untreated
sample contained detectable signal ( ud). Data obtained from BMP-7-treated and TNF--treated cells also are presented for comparison. Ratios marked by asterisk
do no fulfill the requirements for significance (signal greater than twice background and a ratio of greater than /1.8).
(19.8-, 14.0-, 25.4-, 15.5-, and 7.2-fold, respectively, in the tive in reducing IL-6 production, 2.0-fold, compared to
presence of TNF-, Fig. 4B). There was a trend for higher 1.9-, 1.5-, and 0.9-fold for BMP-7, CDMP-1, and TGF-1,
HO-1 expression following BMP-7 treatment, however, respectively. BMP-6 was also the most effective TGF-
these differences were not significant. No changes were superfamily member in reducing MCP-1 production in
noted in HO-2 expression in response to BMP-7 (data PTEC (3.5-fold) followed by TGF-1, BMP-7, and
not shown). CDMP-1 (2.7-, 2.4-, and 1.8-fold, respectively). There-
fore, all but CDMP-1 were effective in reducing MCP-1
The reduction of IL-6 and MCP-1 production by expression by PTEC. However, only BMP-7 and the
BMP-7 is shared by BMP-6 but not by TGF-1 closely related BMP-6 were effective in reducing IL-6
To determine if these responses in PTEC were unique production, demonstrating some level of specificity
to BMP-7 or were shared by other members of the among TGF- superfamily members.
TGF- superfamily, since it has been reported that
TGF-1 can reduce MCP-1 expression in PTEC [21],
DISCUSSIONthe effects of BMP-7, BMP-6, CDMP-1, and TGF-1
Bone morphogenic protein-7 has been demonstratedwere compared on IL-6 and MCP-1 protein production
in PTEC by ELISA (Fig. 5). BMP-6 was the most effec- to maintain kidney function in models of acute and
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MCP-1 and IL-8. Given the important role that PTEC
play in renal inflammation, these changes in expression
provide a potential mechanism by which BMP-7 exerts
its therapeutic effects. Reducing the expression of pro-
inflammatory cytokines may help limit the inflammatory
cascade triggered by the initial insult. The finding that
BMP-7-treatment altered the expression of MCP-1, ET-2,
and Id-3 within three hours of addition also suggests that
these changes could be due to a direct action of BMP-7.
The BMP-7 induced reduction in chemokine expression
including MCP-1 is of particular interest. MCP-1 is pro-
duced by PTEC in response to TNF- and IL-1 [3],
and by plasma proteins associated with proteinuric urine
Fig. 3. Time course of BMP-7 repression of Id-3, MCP-1, and ET-2 [24], and serves as a chemotactic factor for monocytesexpression. PTEC were cultured in the presence or absence of BMP-7
and T-cells. Elevated levels of MCP-1 have been de-(100 ng/mL) and the levels Id-3 (), MCP-1 (), and ET-2 () were
analyzed by quantitative real-time PCR. Values are represented as fold tected in renal tissue in a number of pathologic condi-
change relative to untreated PTEC. tions [25–28], strongly supporting a role for MCP-1 in
renal inflammation and interstitial fibrosis. Indeed, re-
cent data generated in MCP-1/ knockout mice suggest
that elimination of this single chemokine can reduce peri-chronic renal failure [12, 13]. BMP-7 treated animals
tubular macrophage accumulation in a model of nephro-have significantly increased renal blood flow and glomer-
toxic serum nephritis by 40% [29]. Taken together withular flow rate following ureteral obstruction [13], and
the observation that BMP-7 reduced the expression of twolower blood urea nitrogen and serum creatine levels fol-
additional chemokines, IL-8, and growth-related onco-lowing ischemic damage [12]. In both models BMP-7
gene- (Gro-) in PTEC, it is tempting to speculate thattreatment increased survival and histologic parameters,
such effects may underlie the reductions in macrophageincluding a significant reduction in the accumulation of
accumulation observed following renal injury [12, 13].neutrophils within the tubular interstitium. These data
Blocking the influx of inflammatory cells would then re-combined with the requirement of BMP-7 for proper
duce the local release of pro-inflammatory cytokines andembryonic kidney formation [7, 9] suggest that BMP-7
help arrest the progression of the inflammatory response.acts as a maintenance or differentiation factor in kidney
In addition to significant reductions in the pro-inflam-
development and pathophysiology. Despite these obser-
matory cytokines and chemokines, a significant reduction
vations, little is known about the mechanism of BMP-7’s
in the expression of adenosine receptor A1 (ADORA1)
therapeutic action within the kidney. was observed. Adenosine receptors play a role in inflam-
BMP-7 expression (BMP-7/lac-Z mRNA) was higher matory response and also have been implicated in vaso-
in the medullary region of the kidney than in the cortical constriction in the renal system. A flavonoid found in
region (Fig. 1 A, B). A similar medullary distribution of Microtea debilis, cirsimarin, has been used to treat pro-
BMP-7 in the kidney has been reported by others [10, 11]. teinuria and has more recently found to be an antagonist
At the cellular level BMP-7/LacZ expression was de- of the A1 receptor [30, 31]. BMP-7 caused a significant re-
tected in the tubular epithelium of the thick ascending duction in the expression of ADORA1 in PTEC, suggest-
limb, distal convoluted tubule, collecting duct, and in ing another possible mechanism for the observed reduc-
podocytes within the glomerulus (Fig. 1). No detectable tion in neutrophil accumulation and increased GFR in
expression of the BMP-7/LacZ transgene was found in the animal models of renal disease [12, 13]. Renal blood
proximal tubular epithelium (PTEC), confirming what has flow may be enhanced by BMP-7 treatment through the
been observed in a proximal tubule cell-line, HK-2 [22]. observed reduction in endothelin-2 (ET-2) expression by
Given the increased sensitivity of proximal tubules and PTEC. Similarly, BMP-7 was found to increase the ex-
thick ascending limb segments to ischemic injury [16, 17, pression of heme oxygenase 1 (HO-1), a vasodilator, fur-
23], we hypothesize that exogenously added BMP-7 may ther supporting the idea that treatment with BMP-7
provide a maintenance or survival signal for these cells. could lead to an increase in GFR. Recent work has
Our results demonstrate that proximal tubule epithe- suggested that HO-1 expression in human renal epithe-
lial cells (PTEC) express BMP receptors and respond to lial cells is up-regulated by TGF-1, and that this could
BMP-7 both in the presence or absence of the pro-inflam- serve as a protective mechanism in renal disease [32].
matory cytokine TNF-. BMP-7 significantly reduced the Our data show that BMP-7 may act in a similar fashion
basal and TNF-–stimulated expression of the pro-inflam- during renal disease. Interestingly, ET-2 also has been
implicated in stimulating renal fibrosis and BMP-7 hasmatory cytokines IL-6 and IL-1, and the chemokines
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Fig. 4. Quantitative analysis of pro-inflam-
matory, chemokine, and vasoactive gene ex-
pression in PTEC in response to BMP-7.
PTEC were grown for 6 hours in the presence
or absence of BMP-7 (100 ng/mL) and or
TNF- (2 ng/mL). Results are the mean of
three independent experiments each sampled
in triplicate by quantitative real-time PCR and
presented as average fold change compared
to no treatment after normalization to 18S
rRNA. Data are plotted on a log scale with
the value for untreated PTEC set at 1.0. (A)
Genes down-regulated in response to BMP-7.
(B) Genes up-regulated in response to BMP-7.
*Significant difference where P 	 
0.05, and
**where P	
0.005 as determined by the Stu-
dent t test. Table 1 lists the primer sequences
used. Symbols are: ( ) BMP-7; () TNF-;
( ) BMP-7 and TNF-.
been demonstrated to reduce fibrosis associated with PTEC, BMP-7 stimulated the expression of several genes
including Id-1, Id-2, and Id-3, negative regulators of he-unilateral obstruction, a model of chronic renal failure
[12, 13]. Furthermore, BMP-7 has been shown to reduce lix-loop-helix transcription factors, and Smad-6, a factor
involved in down-regulating BMP signaling. The findingthe expression of the endothelin receptor, ET(A), in pri-
mary rat osteoblasts [33], suggesting a broader context in that BMP-7 dramatically up-regulated Id gene expres-
sion is not unexpected as BMP-2 has been reported towhich BMP-7 may regulate endothelin activity. We also
observed a significant increase of ET-1 in response to regulate the expression of Id-1 in embryonic stem cells
[35], osteoblast like cells [36, 37], and in the breast cancerBMP-7 in contrast to the effects of on ET-2. Similar re-
sults have been reported for TGF-, where TGF- en- cell line, MCF-7 [38]. Interestingly, in the normal kidney
abundant Id-1 immunoreactivity has been detected inhanced ET-1 expression while inhibiting ET-2 expression
[34]. Future studies are warranted to extend these in vitro both the distal convoluted tubule and thick ascending limb
[39] both areas found to express high levels of BMP-7/observations into animal models to clearly demonstrate
an effect of BMP-7 on blood flow within the kidney. LacZ mRNA.
Taken together, the data suggest a model by whichIn addition to repressing transcription of genes in
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